Net Loss per Share (Tables)

9 Months Ended

Sep. 30, 2022

Schedule of basic and diluted net income (loss) per share

Basic and diluted net loss per share attributable to common stockholders was calculated as follows (in thousands, except share and per share amounts):


	Three Months Ended September 30,				Nine Months Ended September 30,
	2022		2021		2022		2021
Numerator:
Net income (loss) attributable to common stockholders – basic	$	(18,615)	$	20,807	$	(58,102)	$	(15,676)
Change in fair value for warrant liability	—		(42)		—		—
Interest to convertible notes	—		123		—		—
Loss on extinguishment of debt	—		865		—		—
Change in fair value of derivative liability	—		(475)		—		—
Net income (loss) attributable to common stockholders – diluted	$	(18,615)	$	21,278	$	(58,102)	$	(15,676)



Denominator:
Weighted average common shares outstanding – basic	144,117,273		119,745,196		143,522,555		47,772,253
Weighted average effect of potentially dilutive securities:
Effect of potentially dilutive convertible preferred stock	—		14,065,012		—		—
Effect of potentially dilutive warrants	—		423,271		—		—
Effect of potentially dilutive stock options	—		19,696,440		—		—
Effect of potentially dilutive restricted stock units	—		6,517		—		—
Total potentially dilutive securities	—		34,191,240		—		—
Weighted average common shares outstanding — diluted	144,117,273		153,936,436		143,522,555		47,772,253
Net income (loss) per share attributable to common stockholders - basic	$	(0.13)	$	0.17	$	(0.40)	$	(0.33)
Net income (loss) per share attributable to common stockholders - diluted	$	(0.13)	$	0.14	$	(0.40)	$	(0.33)

Schedule of potential common shares excluded from the computation of diluted net loss per share

The following potentially dilutive outstanding securities were excluded from the computation of diluted net loss per share attributable to common stockholders because their effect would have been anti-dilutive or issuance of such shares is contingent upon the satisfaction of certain conditions which were not satisfied by the end of the period:


	Three Months Ended September 30,		Nine Months Ended September 30,
	2022	2021	2022	2021
Options issued and outstanding	21,027,840	1,589,357	21,027,840	21,285,797
Public Warrants to purchase common stock	14,324,994	14,325,000	14,324,994	14,325,000



Warrants to purchase common stock (Finback)***	2,552,913	2,214,879	2,552,913	2,552,913
Unvested restricted stock units	7,336,179	1,664,567	7,336,179	1,671,084
Unvested performance stock units	889,000	—	889,000	—
Earn-out shares**	15,000,000	15,000,000	15,000,000	15,000,000
Contingently issuable common stock**	1,897,500	1,897,500	1,897,500	1,897,500
Convertible notes (as converted to common stock)*	—	5,408,672	—	5,408,672
	63,028,426	42,099,975	63,028,426	62,140,966

*Conversion feature is only triggered upon the closing of a Qualified Financing Event

**Issuance of Earn-out shares and Contingently issuable common stock are contingent upon the satisfaction of certain conditions, which were not satisfied by the end of the period

***Includes 700,575 vested warrants and 1,852,338 unvested warrants as of September 30, 2022